781 related articles for article (PubMed ID: 8666909)
1. Mechanisms of platelet-activating factor-induced lipid body formation: requisite roles for 5-lipoxygenase and de novo protein synthesis in the compartmentalization of neutrophil lipids.
Bozza PT; Payne JL; Goulet JL; Weller PF
J Exp Med; 1996 Apr; 183(4):1515-25. PubMed ID: 8666909
[TBL] [Abstract][Full Text] [Related]
2. Autocrine enhancement of leukotriene synthesis by endogenous leukotriene B4 and platelet-activating factor in human neutrophils.
McDonald PP; McColl SR; Braquet P; Borgeat P
Br J Pharmacol; 1994 Mar; 111(3):852-60. PubMed ID: 8019762
[TBL] [Abstract][Full Text] [Related]
3. Differential actions of diacyl- and alkylacylglycerols in priming phospholipase A2, 5-lipoxygenase and acetyltransferase activation in human neutrophils.
Bauldry SA; Wykle RL; Bass DA
Biochim Biophys Acta; 1991 Jul; 1084(2):178-84. PubMed ID: 1854803
[TBL] [Abstract][Full Text] [Related]
4. Pathways for eosinophil lipid body induction: differing signal transduction in cells from normal and hypereosinophilic subjects.
Bozza PT; Yu W; Cassara J; Weller PF
J Leukoc Biol; 1998 Oct; 64(4):563-9. PubMed ID: 9766638
[TBL] [Abstract][Full Text] [Related]
5. Interactions between synthesis of platelet-activating factor and leukotriene B4 in isolated human polymorphonuclear leukocytes.
Moilanen E; Kirkkola AL; Kankaanranta H; Nieminen MM; Vapaatalo H
Inflammation; 1993 Dec; 17(6):705-14. PubMed ID: 8112829
[TBL] [Abstract][Full Text] [Related]
6. Neutrophil degranulation: evidence pertaining to its mediation by the combined effects of leukotriene B4, platelet-activating factor, and 5-HETE.
O'Flaherty JT
J Cell Physiol; 1985 Feb; 122(2):229-39. PubMed ID: 2981891
[TBL] [Abstract][Full Text] [Related]
7. Lipopolysaccharide-induced leukocyte lipid body formation in vivo: innate immunity elicited intracellular Loci involved in eicosanoid metabolism.
Pacheco P; Bozza FA; Gomes RN; Bozza M; Weller PF; Castro-Faria-Neto HC; Bozza PT
J Immunol; 2002 Dec; 169(11):6498-506. PubMed ID: 12444160
[TBL] [Abstract][Full Text] [Related]
8. Stimulation and priming of protein kinase C translocation by a Ca2+ transient-independent mechanism. Studies in human neutrophils challenged with platelet-activating factor and other receptor agonists.
O'Flaherty JT; Redman JF; Jacobson DP; Rossi AG
J Biol Chem; 1990 Dec; 265(35):21619-23. PubMed ID: 2174881
[TBL] [Abstract][Full Text] [Related]
9. Eosinophil lipid bodies: specific, inducible intracellular sites for enhanced eicosanoid formation.
Bozza PT; Yu W; Penrose JF; Morgan ES; Dvorak AM; Weller PF
J Exp Med; 1997 Sep; 186(6):909-20. PubMed ID: 9294145
[TBL] [Abstract][Full Text] [Related]
10. Mechanism and regulation of neutrophil priming by platelet-activating factor.
Gay JC
J Cell Physiol; 1993 Jul; 156(1):189-97. PubMed ID: 8391006
[TBL] [Abstract][Full Text] [Related]
11. Anti-inflammatory activities of LDP-392, a dual PAF receptor antagonist and 5-lipoxygenase inhibitor.
Qian C; Hwang SB; Libertine-Garahan L; Eckman JB; Cai X; Scannell RT; Yeh CG
Pharmacol Res; 2001 Sep; 44(3):213-20. PubMed ID: 11529688
[TBL] [Abstract][Full Text] [Related]
12. Leukotriene B4 and platelet activating factor production in permeabilized human neutrophils: role of cytosolic PLA2 in LTB4 and PAF generation.
Bauldry SA; Wooten RE
Biochim Biophys Acta; 1996 Sep; 1303(1):63-73. PubMed ID: 8816854
[TBL] [Abstract][Full Text] [Related]
13. Stimulation of human polymorphonuclear leukocytes by leukotriene B4 and platelet-activating factor: an ultrastructural and pharmacological study.
Rossi AG; MacIntyre DE; Jones CJ; McMillan RM
J Leukoc Biol; 1993 Feb; 53(2):117-25. PubMed ID: 8383164
[TBL] [Abstract][Full Text] [Related]
14. PAF and LTB4 biosynthesis in the human neutrophil: effects of putative inhibitors of phospholipase A2 and specific inhibitors of 5-lipoxygenase.
Glaser KB; Lock YW; Chang JY
Agents Actions; 1991 Sep; 34(1-2):89-92. PubMed ID: 1665306
[TBL] [Abstract][Full Text] [Related]
15. Impaired surface expression of PAF receptors on human neutrophils is dependent upon cell activation.
Zhou W; Javors MA; Olson MS
Arch Biochem Biophys; 1994 Feb; 308(2):439-45. PubMed ID: 8109973
[TBL] [Abstract][Full Text] [Related]
16. Lipoxygenase product formation and cell adhesion during neutrophil-glomerular endothelial cell interaction.
Brady HR; Lamas S; Papayianni A; Takata S; Matsubara M; Marsden PA
Am J Physiol; 1995 Jan; 268(1 Pt 2):F1-12. PubMed ID: 7840235
[TBL] [Abstract][Full Text] [Related]
17. Platelet activating factor stimulates intracellular calcium transients in human neutrophils: involvement of endogenous 5-lipoxygenase products.
Rediske JJ; Quintavalla JC; Haston WO; Morrissey MM; Seligman B
J Leukoc Biol; 1992 May; 51(5):484-9. PubMed ID: 1318349
[TBL] [Abstract][Full Text] [Related]
18. Tenidap inhibits 5-lipoxygenase product formation in vitro, but this activity is not observed in three animal models.
Carty TJ; Sweeney FJ; Griffiths RJ; Eskra JD; Ernest MJ; Pillar JS; Cheng JD; Loose LD; Joseph PA; Pazoles PP; Moore PF; Nagahisa A; Murase S; Kadin SB
Inflamm Res; 1997 May; 46(5):168-79. PubMed ID: 9197987
[TBL] [Abstract][Full Text] [Related]
19. Arachidonate metabolites, platelet-activating factor, and the mobilization of protein kinase C in human polymorphonuclear neutrophils.
O'Flaherty JT; Nishihira J
J Immunol; 1987 Mar; 138(6):1889-95. PubMed ID: 3029224
[TBL] [Abstract][Full Text] [Related]
20. Synergism between platelet-activating factor-like phospholipids and peroxisome proliferator-activated receptor gamma agonists generated during low density lipoprotein oxidation that induces lipid body formation in leukocytes.
de Assis EF; Silva AR; Caiado LF; Marathe GK; Zimmerman GA; Prescott SM; McIntyre TM; Bozza PT; de Castro-Faria-Neto HC
J Immunol; 2003 Aug; 171(4):2090-8. PubMed ID: 12902515
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
